Reliable RT-qPCR-based titration of retroviral and lentiviral vectors via quantification of residual vector plasmid DNA in samples

Abstract

Objectives

To develop a method for reliable quantification of viral vectors, which is necessary for determining the optimal dose of vector particles in clinical trials to obtain the desired effects without severe unwanted immune responses.

Results

A significant level of vector plasmid remained in retroviral and lentiviral vector samples, which led to overestimation of viral titers when using the conventional RT-qPCR-based genomic titration method. To address this problem, we developed a new method in which the residual plasmid was quantified by an additional RT-qPCR step, and standard molecules and primer sets were optimized. The obtained counts were then used to correct the conventionally measured genomic titers of viral samples. While the conventional method produced significantly higher genomic titers for mutant retroviral vectors than for wild-type vectors, our method produced slightly higher or equivalent titers, corresponding with the general idea that mutation of viral components mostly results in reduced or, at best, retained titers.

Conclusion

Subtraction of the number of residual vector plasmid molecules from the conventionally measured genomic titer can yield reliable quantification of retroviral and lentiviral vector samples, a prerequisite to advancing the safety of gene therapy applications.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Barczak W, Suchorska W, Rubis B, Kulcenty K (2015) Universal real-time PCR-based assay for lentiviral titration. Mol Biotechnol 57:195–200

    CAS  Article  PubMed  Google Scholar 

  2. Buchholz CJ, Friedel T, Buning H (2015) Surface-engineered viral vectors for selective and cell type-specific gene delivery. Trend Biotechnol 33:777–790

    CAS  Article  Google Scholar 

  3. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463–8471

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R (2006) Comparison of lentiviral vector titration methods. BMC Biotechnol 6:34

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hacein-Bey Abina S et al (2015) Outcomes following gene therapy in patients with severe Wiskott–Aldrich syndrome. J Am Med Assoc 313:1550–1563

    Article  Google Scholar 

  6. Hacein-Bey-Abina S et al (2014) A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency. New Engl J Med 371:1407–1417

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lim KI, Schaffer DV (2008) Library selection approaches to engineering enhanced retroviral and lentiviral vectors. Comb Chem High Throughput Screen 11:111–117

    CAS  Article  PubMed  Google Scholar 

  8. Lim KI, Klimczak R, Yu JH, Schaffer DV (2010) Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties. Proc Natl Acad Sci USA 107:12475–12480

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868–872

    CAS  Article  PubMed  Google Scholar 

  10. Schaffer DV, Koerber JT, Lim KI (2008) Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng 10:169–194

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. Scherr M, Battmer K, Blomer U, Ganser A, Grez M (2001) Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 31:520, 522, 524 (passim)

  12. Towers GJ, Stockholm D, Labrousse-Najburg V, Carlier F, Danos O, Pages JC (1999) One step screening of retroviral producer clones by real time quantitative PCR. J Gen Med 1:352–359

    CAS  Article  Google Scholar 

  13. Vermeire J, Naessens E, Vanderstraeten H, Landi A, Iannucci V, Nuffel AV, Taghon T, Pizzato M, Verhasselt B (2012) Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. PLoS ONE 7:e50859

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This research was supported by the Sookmyung Women’s University Research Grants 2012.

Author contributions

YJ and KL designed the study. YJ performed most experiments, and HS and YY contributed in part to the experiments. YJ and KL analyzed the experimental data and wrote the manuscript.

Supporting Information

Supplementary Table 1—Primer sets used in RT-qPCR.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kwang-il Lim.

Ethics declarations

Conflict of Interests

The authors declare no competing interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 65 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jang, Yh., Song, Hi., Yang, Y. et al. Reliable RT-qPCR-based titration of retroviral and lentiviral vectors via quantification of residual vector plasmid DNA in samples. Biotechnol Lett 38, 1285–1291 (2016). https://doi.org/10.1007/s10529-016-2110-7

Download citation

Keywords

  • Gene therapy
  • Genomic titer
  • Human embryonic kidney cells
  • Plasmid contamination
  • Retroviral vectors
  • RT-Qpcr
  • Viral vectors